Learn about BYETTA, the BYETTA Pen. in patients with prior severe hypersensitivity reactions to exenatide or to any of the product components. Patient Information Leaflet. Package leaflet: Information for the patient. Byetta 5 micrograms solution for injection in pre-filled pen. Byetta 10 micrograms solution . Easy to read FDA package insert, drug facts, dosage and administration, and adverse effects for Byetta (Exenatide).
|Published (Last):||25 December 2017|
|PDF File Size:||10.40 Mb|
|ePub File Size:||12.95 Mb|
|Price:||Free* [*Free Regsitration Required]|
Stop taking BYETTA and packabe your healthcare provider byetta package insert away if you have pain in your stomach area abdomen that is severe, and will not go away, occurs with or without vomiting or is felt going from your abdomen through to your back. All other trademarks are property of their respective owners. Go to Patient Site.
Beytta other trademarks are property of their respective owners. Based on animal data, BYETTA may cause fetal harm and should be used during pregnancy only if the potential byetta package insert justifies the potential risk to the fetus.
Add BYETTA to insulin glargine as a complementary action to help improve glycemic control
Postmarketing reports byetta package insert increased international normalized ratio INR sometimes associated with bleeding with concomitant use of warfarin.
Pen-sharing poses a risk for transmission of blood-borne pathogens, even if the needle is changed. You may give other people a serious infection, or get a serious infection from them. Tell your healthcare provider if you have or had kidney problems or a kidney transplant. This packsge information is intended for US Healthcare Professionals only. byetta package insert
Use of twice-daily exenatide in basal insulin—treated patients with type 2 diabetes: To report drug exposure during pregnancy call If worsening of or failure to achieve adequate glycemic control occurs, consider alternative antidiabetic therapy. Inflammation of the pancreas pancreatitis may byetta package insert, onsert may be severe and lead to death. Call your healthcare provider right away if you have nausea, vomiting, or diarrhea that will not go away, or if you cannot take liquids by mouth.
Go to Healthcare Professional Site. Increased risk of hypoglycemia when used in combination with inssert sulfonylurea SU or when used with a glucose-independent insulin secretagogues eg, meglitinides. Patients may develop antibodies to exenatide.
Because exenatide is commonly associated with gastrointestinal adverse reactions, BYETTA is not recommended in patients with severe gastrointestinal disease eg gastroparesis. You byetta package insert report side effects related to AstraZeneca products by clicking here.
Not a substitute for insulin and should byetta package insert be used in patients with type 1 diabetes or diabetic ketoacidosis. Tell your healthcare provider if you have severe problems with your stomach, such as delayed emptying of your stomach gastroparesis or problems byetta package insert digesting food. Oral medications dependent on threshold concentrations for efficacy, such as contraceptives or antibiotics, should be taken at least 1 hour before BYETTA.
BYETTA should not be used in people with type 1 byetta package insert or people with diabetic ketoacidosis a condition caused by very high blood sugar. The Double B logo is a trademark of the AstraZeneca group of companies. This site is intended for US Consumers.
Official BYETTA® (exenatide) injection Healthcare Professional Website
Your risk for getting low blood sugar hypoglycemia is higher if you take BYETTA with another medicine that can cause byetta package insert blood sugar, such as a sulfonylurea or insulin. You are encouraged to report negative side effects of prescription drugs to the FDA.
No placebo-treated patients withdrew due to nausea or vomiting.
Glucagon-like peptide-1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes. BYETTA is byetta package insert injectable prescription medicine that may improve blood sugar glucose control in adults with type 2 diabetes, when used with diet and exercise.
Postmarketing reports of serious hypersensitivity reactions eg anaphylaxis and angioedema. Approved Uses BYETTA is an injectable prescription medicine that may improve byetta package insert sugar glucose control in adults with type 2 diabetes, when used with diet and exercise.
Before taking BYETTA, tell your healthcare provider if you have had byetta package insert, stones in your gallbladder gallstonesa history of alcoholism, or high blood triglyceride levels. Use with caution with medications hyetta have a narrow therapeutic index or require rapid gastrointestinal absorption. If pancreatitis is suspected, BYETTA should be discontinued promptly and should not be restarted if pancreatitis is confirmed.